Annual Net Income
-$42.77 M
-$10.98 M-34.53%
December 31, 2023
Summary
- As of February 26, 2025, CLRB annual net profit is -$42.77 million, with the most recent change of -$10.98 million (-34.53%) on December 31, 2023.
- During the last 3 years, CLRB annual net income has fallen by -$27.68 million (-183.36%).
- CLRB annual net income is now -1300.75% below its all-time high of -$3.05 million, reached on December 31, 2005.
Performance
CLRB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$14.66 M
-$13.75 M-1495.03%
September 30, 2024
Summary
- As of February 26, 2025, CLRB quarterly net profit is -$14.66 million, with the most recent change of -$13.75 million (-1495.03%) on September 30, 2024.
- Over the past year, CLRB quarterly net income has stayed the same.
- CLRB quarterly net income is now -374.10% below its all-time high of $5.35 million, reached on March 31, 2010.
Performance
CLRB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$50.11 M
+$2.86 M+5.39%
September 30, 2024
Summary
- As of February 26, 2025, CLRB TTM net profit is -$50.11 million, with the most recent change of +$2.86 million (+5.39%) on September 30, 2024.
- Over the past year, CLRB TTM net income has stayed the same.
- CLRB TTM net income is now -2052.51% below its all-time high of $2.57 million, reached on December 31, 2010.
Performance
CLRB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CLRB Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.5% | 0.0% | 0.0% |
| 3 y3 years | -183.4% | -152.0% | -129.7% |
| 5 y5 years | -223.1% | -275.6% | -255.6% |
CLRB Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -77.3% | at low | -1495.0% | +45.0% | -109.6% | +19.5% |
| 5 y | 5-year | -203.5% | at low | -1495.0% | +45.0% | -255.6% | +19.5% |
| alltime | all time | -1300.8% | at low | -374.1% | +45.0% | -2052.5% | +19.5% |
Cellectar Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.66 M(+1495.0%) | -$50.11 M(-5.4%) |
| Jun 2024 | - | -$919.40 K(-96.5%) | -$52.96 M(-14.9%) |
| Mar 2024 | - | -$26.64 M(+238.0%) | -$62.22 M(+45.5%) |
| Dec 2023 | -$42.77 M(+34.5%) | -$7.88 M(-55.0%) | -$42.77 M(-5.6%) |
| Sep 2023 | - | -$17.52 M(+72.1%) | -$45.30 M(+27.3%) |
| Jun 2023 | - | -$10.18 M(+41.6%) | -$35.59 M(+8.4%) |
| Mar 2023 | - | -$7.19 M(-30.9%) | -$32.84 M(+3.3%) |
| Dec 2022 | -$31.79 M(+31.8%) | -$10.41 M(+33.2%) | -$31.79 M(+16.4%) |
| Sep 2022 | - | -$7.81 M(+5.1%) | -$27.30 M(+7.9%) |
| Jun 2022 | - | -$7.43 M(+21.1%) | -$25.31 M(+5.9%) |
| Mar 2022 | - | -$6.14 M(+3.7%) | -$23.91 M(-0.9%) |
| Dec 2021 | -$24.12 M(+59.8%) | -$5.92 M(+1.7%) | -$24.12 M(+10.6%) |
| Sep 2021 | - | -$5.82 M(-3.5%) | -$21.82 M(+9.6%) |
| Jun 2021 | - | -$6.03 M(-5.2%) | -$19.91 M(+13.8%) |
| Mar 2021 | - | -$6.36 M(+75.9%) | -$17.49 M(+15.9%) |
| Dec 2020 | -$15.09 M(+7.1%) | -$3.62 M(-7.5%) | -$15.09 M(+1.6%) |
| Sep 2020 | - | -$3.91 M(+8.2%) | -$14.86 M(+0.0%) |
| Jun 2020 | - | -$3.61 M(-8.7%) | -$14.85 M(+2.9%) |
| Mar 2020 | - | -$3.96 M(+17.1%) | -$14.43 M(+2.4%) |
| Dec 2019 | -$14.09 M(+6.4%) | -$3.38 M(-13.4%) | -$14.09 M(-3.1%) |
| Sep 2019 | - | -$3.90 M(+22.5%) | -$14.54 M(+6.5%) |
| Jun 2019 | - | -$3.19 M(-12.0%) | -$13.65 M(+2.0%) |
| Mar 2019 | - | -$3.62 M(-5.4%) | -$13.38 M(+1.1%) |
| Dec 2018 | -$13.24 M(-2.4%) | -$3.83 M(+27.0%) | -$13.24 M(-1.9%) |
| Sep 2018 | - | -$3.01 M(+3.2%) | -$13.49 M(-3.3%) |
| Jun 2018 | - | -$2.92 M(-16.0%) | -$13.95 M(-1.4%) |
| Mar 2018 | - | -$3.48 M(-14.8%) | -$14.15 M(+4.3%) |
| Dec 2017 | -$13.56 M(+119.4%) | -$4.08 M(+17.5%) | -$13.56 M(+12.4%) |
| Sep 2017 | - | -$3.47 M(+11.2%) | -$12.07 M(+10.9%) |
| Jun 2017 | - | -$3.12 M(+8.0%) | -$10.88 M(+10.0%) |
| Mar 2017 | - | -$2.89 M(+11.8%) | -$9.90 M(+60.1%) |
| Dec 2016 | -$6.18 M(+12.5%) | -$2.59 M(+13.0%) | -$6.18 M(+133.7%) |
| Sep 2016 | - | -$2.29 M(+7.2%) | -$2.64 M(+19.3%) |
| Jun 2016 | - | -$2.13 M(-358.7%) | -$2.22 M(-6.5%) |
| Mar 2016 | - | $824.60 K(-13.3%) | -$2.37 M(-56.9%) |
| Dec 2015 | -$5.50 M(-31.8%) | $950.90 K(-151.2%) | -$5.50 M(-43.9%) |
| Sep 2015 | - | -$1.86 M(-18.7%) | -$9.79 M(+28.7%) |
| Jun 2015 | - | -$2.29 M(-0.6%) | -$7.61 M(+2.7%) |
| Mar 2015 | - | -$2.30 M(-31.2%) | -$7.41 M(-8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$8.05 M(-25.3%) | -$3.35 M(-1133.0%) | -$8.05 M(-7.0%) |
| Sep 2014 | - | $324.00 K(-115.5%) | -$8.65 M(-15.9%) |
| Jun 2014 | - | -$2.09 M(-29.1%) | -$10.29 M(+0.2%) |
| Mar 2014 | - | -$2.94 M(-25.5%) | -$10.27 M(-4.7%) |
| Dec 2013 | -$10.78 M(+22.6%) | -$3.95 M(+200.2%) | -$10.78 M(+19.9%) |
| Sep 2013 | - | -$1.32 M(-36.3%) | -$8.99 M(-7.6%) |
| Jun 2013 | - | -$2.06 M(-40.2%) | -$9.73 M(-1.7%) |
| Mar 2013 | - | -$3.45 M(+60.1%) | -$9.89 M(+12.5%) |
| Dec 2012 | -$8.80 M(+18.3%) | -$2.16 M(+5.1%) | -$8.80 M(+2.2%) |
| Sep 2012 | - | -$2.05 M(-8.0%) | -$8.61 M(+1.7%) |
| Jun 2012 | - | -$2.23 M(-5.4%) | -$8.46 M(-4.1%) |
| Mar 2012 | - | -$2.36 M(+19.9%) | -$8.83 M(+18.7%) |
| Dec 2011 | -$7.44 M(+63.0%) | -$1.97 M(+3.0%) | -$7.44 M(+25.4%) |
| Sep 2011 | - | -$1.91 M(-26.4%) | -$5.93 M(+25.6%) |
| Jun 2011 | - | -$2.60 M(+168.8%) | -$4.72 M(+26.0%) |
| Mar 2011 | - | -$965.30 K(+109.0%) | -$3.75 M(-246.1%) |
| Dec 2010 | -$4.56 M(-79.5%) | -$461.80 K(-34.0%) | $2.57 M(-126.1%) |
| Sep 2010 | - | -$700.20 K(-56.8%) | -$9.83 M(-17.2%) |
| Jun 2010 | - | -$1.62 M(-130.3%) | -$11.88 M(-21.4%) |
| Mar 2010 | - | $5.35 M(-141.6%) | -$15.11 M(-32.2%) |
| Dec 2009 | -$22.27 M(+35.4%) | -$12.86 M(+368.8%) | -$22.27 M(+92.8%) |
| Sep 2009 | - | -$2.74 M(-43.5%) | -$11.55 M(+1.8%) |
| Jun 2009 | - | -$4.86 M(+167.8%) | -$11.34 M(+1.6%) |
| Mar 2009 | - | -$1.81 M(-15.2%) | -$11.16 M(-32.1%) |
| Dec 2008 | -$16.45 M(-15.9%) | -$2.14 M(-15.6%) | -$16.45 M(-21.1%) |
| Sep 2008 | - | -$2.53 M(-45.8%) | -$20.85 M(-15.7%) |
| Jun 2008 | - | -$4.68 M(-34.1%) | -$24.73 M(+1.9%) |
| Mar 2008 | - | -$7.10 M(+8.6%) | -$24.28 M(+24.1%) |
| Dec 2007 | -$19.56 M(+136.0%) | -$6.54 M(+1.9%) | -$19.56 M(+24.6%) |
| Sep 2007 | - | -$6.41 M(+52.0%) | -$15.69 M(+29.9%) |
| Jun 2007 | - | -$4.22 M(+77.3%) | -$12.08 M(+29.7%) |
| Mar 2007 | - | -$2.38 M(-10.9%) | -$9.31 M(+12.4%) |
| Dec 2006 | -$8.29 M(+171.4%) | -$2.67 M(-4.6%) | -$8.29 M(+31.1%) |
| Sep 2006 | - | -$2.80 M(+92.2%) | -$6.32 M(+41.3%) |
| Jun 2006 | - | -$1.46 M(+7.6%) | -$4.47 M(+11.9%) |
| Mar 2006 | - | -$1.35 M(+92.1%) | -$4.00 M(+30.9%) |
| Dec 2005 | -$3.05 M | -$704.90 K(-26.2%) | -$3.05 M(+30.0%) |
| Sep 2005 | - | -$954.90 K(-2.8%) | -$2.35 M(+68.5%) |
| Jun 2005 | - | -$982.90 K(+139.3%) | -$1.39 M(+239.3%) |
| Mar 2005 | - | -$410.70 K | -$410.70 K |
FAQ
- What is Cellectar Biosciences annual net profit?
- What is the all time high annual net income for Cellectar Biosciences?
- What is Cellectar Biosciences annual net income year-on-year change?
- What is Cellectar Biosciences quarterly net profit?
- What is the all time high quarterly net income for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly net income year-on-year change?
- What is Cellectar Biosciences TTM net profit?
- What is the all time high TTM net income for Cellectar Biosciences?
- What is Cellectar Biosciences TTM net income year-on-year change?
What is Cellectar Biosciences annual net profit?
The current annual net income of CLRB is -$42.77 M
What is the all time high annual net income for Cellectar Biosciences?
Cellectar Biosciences all-time high annual net profit is -$3.05 M
What is Cellectar Biosciences annual net income year-on-year change?
Over the past year, CLRB annual net profit has changed by -$10.98 M (-34.53%)
What is Cellectar Biosciences quarterly net profit?
The current quarterly net income of CLRB is -$14.66 M
What is the all time high quarterly net income for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly net profit is $5.35 M
What is Cellectar Biosciences quarterly net income year-on-year change?
Over the past year, CLRB quarterly net profit has changed by $0.00 (0.00%)
What is Cellectar Biosciences TTM net profit?
The current TTM net income of CLRB is -$50.11 M
What is the all time high TTM net income for Cellectar Biosciences?
Cellectar Biosciences all-time high TTM net profit is $2.57 M
What is Cellectar Biosciences TTM net income year-on-year change?
Over the past year, CLRB TTM net profit has changed by $0.00 (0.00%)